china glp 1 More Chinese biotechs challenge GLP-1 dominance in diabetes Rival GLP-1 Weight-Loss Drug Emerges

GLOBAL GLUTATHIONE MARKET SIZE, BY CREAMS, BY GROUP, 2018-2032 (USD MILLION) TABLE 13

A few medications have been repurposed to address metabolic disturbances, such as the insulin sensitiser metformin, widely used for the treatment of PCOS since the 1990s

On the data side, the Lau phase 2 obesity trial showed Cagrilintide monotherapy producing dose-related weight loss, reaching close to 10.8 percent at the top dose over roughly 26 weeks, against about 3 percent on placebo

Strategies for managing GLP-1 side effects (nausea, fatigue)

A separate analysis estimated that roughly 45% of weight lost was lean tissue

Another key metabolic element in lung cancer is that Nrf2 controls the expression of genes encoding serine/glycine biosynthesis enzymes to support nucleotide production and tumour cell growth